Publications found:
30,417
Sort by:
North America: Vitamins Market
US$ 1,999.00
... report on the vitamins market in North America covers the following countries: Canada, Mexico, and the United States of America. The report on the vitamins market in North America includes: Analysis and ...
October 2021
150 pages
2022 U.S. Drywall & Insulation Contractors Industry-Industry & Market Report
US$ 149.00
The 2019 U.S. Drywall & Insulation Contractors Industry-Industry & Market Report, published annually by Barnes Reports, ... features 2019 current and 2020 forecast estimates on the size of the industry (sales, establishments, employment) nationally and for all 50 U.S. States and ...
October 2021
195 pages
2022 U.S. Pharmaceutical Preparation Mfg.. Industry-Industry & Market Report
US$ 149.00
The 2019 U.S. Pharmaceutical Preparation Manufacturing Industry-Industry & Market report, published annually by Barnes Reports, ... features 2019 current and 2020 forecast estimates on the size of the industry (sales, establishments, employment) nationally and for all 50 U.S. States and ...
October 2021
195 pages
2022 U.S. Pharmacies & Drug Stores Industry-Industry & Market Report
US$ 149.00
The 2019 U.S. Pharmacies & Drug Stores Industry-Industry & Market report, published annually by Barnes Reports, ... features 2019 current and 2020 forecast estimates on the size of the industry (sales, establishments, employment) nationally and for all 50 U.S. States and ...
October 2021
195 pages
Pharmaceutical Contract Development and Manufacturing Market (Pharmaceutical, Biologics, Active Pharma ingredients, tablet, Parenteral, Oral Liquid, Semi-Solids), End User (Big Pharma, Small Pharma, Generic Pharma, CRO)-Global Forecast to 2026
US$ 4,950.00
... pharmaceutical contract development and manufacturing market is segmented into pharmaceutical manufacturing, biologics manufacturing, and drug development services. The biologics manufacturing segment is projected to witness the highest growth in the pharmaceutical contract development and manufacturing ...
October 2021
242 pages
Natural Source Vitamin E (Tocopherols and Tocotrienols) – A Global Market Overview
US$ 4,500.00
... 8.5 thousand metric tons in 2018. Research Findings & Coverage Global Natural Source Vitamin E market is analyzed in this report with respect to key ... the following key product types of Natural Vitamin E: Tocopherols Tocotrienols End-Use sectors of Natural Vitamin E analyzed comprise the following: Animal ...
October 2021
278 pages
Analgesics in the United Kingdom
US$ 990.00
... OTC category after cough, cold and al... Euromonitor International's Analgesics in United Kingdom report offers a comprehensive guide to the size and shape ... the market is set to change. Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic. Data coverage: market sizes (historic and forecasts), ...
October 2021
27 pages
Digestive Remedies in the United Kingdom
US$ 990.00
... National Institute for Health Research as a public health... Euromonitor International's Digestive Remedies in United Kingdom report offers a comprehensive guide to the size and shape of the ...
October 2021
27 pages
NRT Smoking Cessation Aids in the United Kingdom
US$ 990.00
... Figures also show that the percentage... Euromonitor International's NRT Smoking Cessation Aids in United Kingdom report offers a comprehensive guide to the size and shape ... this report? Get a detailed picture of the NRT Smoking Cessation Aids market; Pinpoint growth sectors and identify factors driving change ...
October 2021
24 pages
Global Diagnostic Imaging Partnering Terms and Agreements 2014 to 2021
US$ 3,495.00
... imaging partnering deals. This report provides details of the latest diagnostics agreements announced in the healthcare sectors, covering: Imaging CT Endoscope Molecular and nuclear PET SPECT MRI Ultrasound X ray Angiography Fluoroscopy Mammography This report provides an overview of diagnostic imaging ...
October 2021
550 pages
Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2021
US$ 3,495.00
... including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche ...
October 2021
550 pages
Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2016-2021
US$ 3,495.00
... including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche ...
October 2021
2500 pages
Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2015-2021
US$ 3,495.00
... latest licensing agreements announced in the pharmaceutical, biotechnology ... licensing deals by value since 2014 Most active licensing dealmakers since 2014 The leading licensing partnering resources In Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014- 2019 available deals ...
October 2021
2600 pages
Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2021
US$ 3,495.00
... including the technology licensed, royalty rates, license fees, upfront and milestone payments. DESCRIPTION The Global Royalty Rate Trends in Pharma ... licensed, royalty rates, license fees, upfront and milestone payments. This report provides details of the latest partnering deals which disclose a royalty rate ...
October 2021
500 pages
Basal cell carcinoma - Pipeline Insight, 2021
US$ 2,000.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Basal Cell Carcinoma (Basal Cell Epithelioma) The report also ...
October 2021
70 pages
Chondrosarcoma - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Chondrosarcoma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Chondrosarcoma development. The report provides detailed ...
October 2021
60 pages
Binge-eating disorder - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Binge Disorders - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Binge Disorders development. The report provides ...
October 2021
60 pages
Herpes labialis - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Herpes Labialis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Herpes Labialis development. The report provides ...
October 2021
60 pages
Hypertriglyceridemia - Pipeline Insight, 2021
US$ 2,000.00
... clients within 48 Hours 'Hypertriglyceridemia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Hypertriglyceridemia development. The report provides detailed ...
October 2021
60 pages
Liposarcoma - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Liposarcoma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Liposarcoma development. The report provides detailed ...
October 2021
60 pages
Medulloblastoma - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Medulloblastoma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Medulloblastoma development. The report provides detailed ...
October 2021
60 pages
Myelofibrosis - Pipeline Insight, 2021
US$ 2,000.00
... clients within 48 Hours 'Myelofibrosis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Myelofibrosis development. The report provides detailed ...
October 2021
80 pages
Peptic Ulcer - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Peptic Ulcers - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Peptic Ulcers development. The report provides ...
October 2021
60 pages
Pulmonary Embolism - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Pulmonary Embolism - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Pulmonary Embolism development. The report provides ...
October 2021
60 pages
Rosacea - Pipeline Insight, 2021
US$ 2,000.00
... clients within 48 Hours 'Rosacea - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Rosacea development. The report provides detailed ...
October 2021
60 pages
Narcolepsy - Pipeline Insight, 2021
US$ 1,500.00
... Narcolepsy - Pipeline Insight, 2018' report by DelveInsight outlays comprehensive Insight of present scenario and growth prospects across Narcolepsy. A detailed picture of the pipeline ... and Discontinued) Overview of pipeline development activities for Narcolepsy Pipeline analysis of therapeutic drugs include ...
October 2021
60 pages
Ataxia-telangiectasia - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 hours DelveInsight’s, “Ataxia-telangiectasia - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipelin...
October 2021
60 pages
Beta-thalassaemia - Pipeline Insight, 2021
US$ 2,000.00
This report can be delivered to the clients within 3-4 Business Days DelveInsight’s, “Beta-thalassaemia - Pipeline Insight, 2021,” report provides comprehensive insights about 22+ companies and 22+...
October 2021
60 pages
Bullous pemphigoid - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 3-4 Business Days DelveInsight’s, “Bullous pemphigoid - Pipeline Insight, 2021,” report provides comprehensive insights about 8+ companies and 8+ p...
October 2021
60 pages
Carcinoid Syndrome - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 hours DelveInsight’s, “Carcinoid Syndrome - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline d...
October 2021
60 pages
Gaucher’s Disease - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Gaucher’s Disease - Pipeline Insight, 2021,” report provides comprehensive insights about 14+ companies and 16+ pipeline...
October 2021
60 pages
Lyme Disease - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 72 hours DelveInsight’s, “Lyme Disease - Pipeline Insight, 2021,” report provides comprehensive insights about 7+ companies and 7+ pipeline drugs i...
October 2021
60 pages
Muscle Spasticity - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Muscle Spasticity – Pipeline Insight, 2021,” report provides comprehensive insights about 8+ companies and 8+ pipeline dr...
October 2021
60 pages
Neurofibromatosis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Neurofibromatosis - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline...
October 2021
60 pages
Presbyopia - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Presbyopia - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs i...
October 2021
60 pages
Primary Ciliary Dyskinesia - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 hours DelveInsight’s, “Primary Ciliary Dyskinesia – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pi...
October 2021
60 pages
Chronic Rhinosinusitis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Chronic Rhinosinusitis - Pipeline Insight, 2021,” report provides comprehensive insights about 6+ companies and 6+ pipeli...
October 2021
60 pages
Keloids - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 hours DelveInsight’s, “Keloids - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Kel...
October 2021
60 pages
Ocular Inflammation and Pain - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 hours DelveInsight’s, “Ocular Inflammation and Pain – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+...
October 2021
60 pages
Hemochromatosis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 hours DelveInsight’s, “Hemochromatosis – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline drug...
October 2021
60 pages
Immune Thrombocytopenic Purpura - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Immune Thrombocytopenic Purpura - Pipeline Insight, 2021,” report provides comprehensive insights about 18+ companies and...
October 2021
60 pages
Osteonecrosis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 hours DelveInsight’s, “Osteonecrosis – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs...
October 2021
60 pages
Peritoneal Cancer - Pipeline Insight, 2021
US$ 2,500.00
This report can be delivered to the clients within 5-6 business days DelveInsight’s, “Peritoneal cancer – Pipeline Insight, 2021,” report provides comprehensive insights about 50+ companies and 50+...
October 2021
60 pages
